Keywords: ibt, invests, million, canada, inflazyme, pharmaceuticals, international
IBT invests $8.1 million in Canada's Inflazyme Pharmaceuticals
Article | 06 June 2000
International Biotechnology Trust has purchased almost 3.9 millionshares in Inflazyme Pharmaceuticals of Canada at a total cost of C$12 million ($8.1 million). ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
